Please assess the completion status of the following clinical trial:

Trial Title: Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 years and older~* Diagnosis: single, cytology-proven papillary thyroid carcinoma measuring 1 cm or less in diameter (microcarcinoma, T1a), without visible extrathyroidal extension, and with negative central and lateral neck lymph nodes by ultrasound~Exclusion Criteria:~* Patient refusal to participate~* History of prior thyroid or parathyroid surgery~* Previous recurrent laryngeal nerve injury~* Inability to make decisions or comply with follow up~* Co-existing indication for thyroidectomy~* Aggressive cytological or molecular features~* Multifocal papillary thyroid carcinoma~* Pregnant or breast-feeding~* Anatomically unfavorable location of the tumor (proximity to recurrent laryngeal nerve or trachea)~* Documented or suspected distant metastasis~* History of radiation to neck or face~* Family history of thyroid cancer

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- percutaneous ethanol ablation (Type: EXPERIMENTAL): The experimental group of the study is comprised of patients that will undergo percutaneous ethanol ablation for the management of papillary thyroid microcarcinoma.

Based on this trial design, predict the completion outcome and termination type (if applicable).